MOTS-c peptide
Selected indexed studies
- MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. (Front Endocrinol (Lausanne), 2023) [PMID:36761202]
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. (Cell Metab, 2015) [PMID:25738459]
- Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 Deubiquitination. (Adv Sci (Weinh), 2024) [PMID:39321430]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. (2023) pubmed
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. (2015) pubmed
- Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 Deubiquitination. (2024) pubmed
- The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus. (2022) pubmed
- Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging. (2023) pubmed
- Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases. (2023) pubmed
- MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases. (2022) pubmed
- The Mitochondrial-Encoded Peptide MOTS-c Translocates to the Nucleus to Regulate Nuclear Gene Expression in Response to Metabolic Stress. (2018) pubmed
- Mitochondria-encoded peptide MOTS-c participates in plasma membrane repair by facilitating the translocation of TRIM72 to membrane. (2024) pubmed
- The Mitochondrial-Derived Peptide MOTS-c Alleviates Radiation Pneumonitis via an Nrf2-Dependent Mechanism. (2024) pubmed